Tempest Therapeutics, Inc.
TPST
$6.90
$0.294.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.19% | 6.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.43% | 31.91% | |||
| Operating Income | 21.43% | -31.91% | |||
| Income Before Tax | 21.38% | -30.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.38% | -30.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.38% | -30.85% | |||
| EBIT | 21.43% | -31.91% | |||
| EBITDA | 21.64% | -32.67% | |||
| EPS Basic | 27.88% | 17.62% | |||
| Normalized Basic EPS | 27.88% | 17.62% | |||
| EPS Diluted | 27.88% | 17.62% | |||
| Normalized Diluted EPS | 27.88% | 17.62% | |||
| Average Basic Shares Outstanding | 9.02% | 58.85% | |||
| Average Diluted Shares Outstanding | 9.02% | 58.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||